De Facto Insider James Farinella of Integrated Capital Partners Appears to Secretly Pump Pazoo While Dumping Shares

There are now over 300 cannabis-related stocks in the universe that 420 Investor tracks. Most of these companies are not anything more than opportunists, though there are several real companies. Pazoo (PZOO) is a penny stock that jumped in to the frenzy at the top, announcing in early 2014 that it was extending from the human and animal health and wellness business into the burgeoning cannabis testing lab business. Ordinarily, this type of business move should be viewed cynically, but in the case of PZOO, it inked a deal with an entity, MA Associates, with a license with highly respected Steep Hill Labs to open a testing lab in Las Vegas using its name and operating procedures. PZOO now owns 100% of MA Associates, which won a license from the state in November.

When I launched coverage of PZOO on June 1st, including it in my Focus List, I suggested that it is among the most promotional stocks in the space. StockPromoters.com indicates that the company has had 560 promotions since going public three years ago, but, to be fair, some of these are traditional I.R. activities. Many, though, are of a more vile nature, like a third-party entity, OT Group, LLC, spending $175K over July 9-10, a time during which the company also engaged Small Cap Voice and Bull In Advantage to help spread the word while it released three separate press releases within 24 hours as the CEO conducted interviews with Money TV and Green Baron as well.

As I have mentioned, Pazoo faces a serious cash crunch. The company has invested in the buildout of its Nevada lab, but it still isn't open. In fact, according to the CEO as conveyed in the recent conference call, the company still doesn't have a certificate ...

Read More
Comments

Here Come the Marijuana Money Managers

I am really excited about a material change that has positive implications for the cannabis industry, as several new companies have formed that will invest in the cannabis industry on behalf of their clients. I am calling this group the ...

Read More
Comments

Cannabis Science (CBIS) Alters Capital Structure 4 Years Later

Today, Cannabis Science (CBIS) announced that it will be issuing a stock dividend after it files a definitive proxy. The company issued an 8-K filing as well as a press release:

Cannabis Science to Issue Dividend Payouts for Previous and ...

Read More
Comments

Hemp Hucksters?

I saw a press release today for "Organic CBD oil made in America GreenLeaf Farms" that asserts that the company is "the first company to offer true all organic CBD oil made in America". The press release has two images ...

Read More
Comments

Good Info from the SEC

http://www.sec.gov/oiea/investor-alerts-bulletins/...

The SEC’s Office of Investor Education and Advocacy is issuing this Investor Alert to warn investors about fraudsters who promote a stock to drive up the stock price and then sell their own ...

Read More
Comments

Why PZOO May Move to New Lows

Today, Pazoo, Inc. (PZOO) filed another preliminary proxy in advance of a dramatic boost to its authorized shares. The company is raising its common share authorization by almost 2 billion to 2.95 billion from 0.98 billion. It is ...

Read More
Comments

Slides from Houlihan's Valuation of Kannaway for MJNA

5 weeks ago, MJNA announced that it was buying Kannaway, the MLM that distributes some of its products. The press release, which didn't detail the terms of the transaction, alluded to a valuation analysis performed by Houlihan Capital that ...

Read More
Comments

A Good Time to Grab Some GW Pharma

UK-based GW Pharma (GWPH) is allowing long-term investors a good entry today following the release of Q1 results and a conference call that followed.  The stock continued to retrace a good portion of its massive rally in early January today but ...

Read More
Comments

MJNA: It's What They Didn't Say About Kannaway That Should Make You Run Away

In typical fashion for the company, Medical Marijuana, Inc. (MJNA) dropped an aggressive press release lacking substance in what appears to be a last-ditch effort to interest investors in its comatose stock.  Before the market opened on 1/22/15 ...

Read More
Comments

Red Ahead for this Black Eye of the Green Rush

In a move that has been signaled by a brewing battle, Medbox (MDBX) founder and controlling shareholder Vincent Mehdizadeh moved today to replace the entire Board of Directors.  In a definitive proxy filed with the SEC, Mehdizadeh named himself, employees  ...

Read More
Comments

Pot Stocks Pay Off: A Review of the Cannabis Sector

NOTE:  This is satire

What a year it was for the marijuana sector, bouncing back from a challenging 2014. While the sector ended the year well below the 2014 highs despite more than tripling in price, investors are optimistic that ...

Read More
Comments

420 Investor Interview: Paul Rosen, CEO of PharmaCan Capital

One of the most exciting themes for those looking to capitalize on the changing global cannabis industry is the rollout of Canada's Marihuana for Medical Purposes Regulations (MMPR). Health Canada, which oversees Canada’s national medical marijuana program, has ...

Read More
Comments